• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿液药物筛查:一项有价值的门诊程序。

Urine drug screening: a valuable office procedure.

机构信息

Health Science Center, University of Tennessee College of Medicine, 1100 E. 3rd Street, Chattanooga, TN 37403, USA.

出版信息

Am Fam Physician. 2010 Mar 1;81(5):635-40.

PMID:20187600
Abstract

Urine drug screening can enhance workplace safety, monitor medication compliance, and detect drug abuse. Ordering and interpreting these tests requires an understanding of testing modalities, detection times for specific drugs, and common explanations for false-positive and false-negative results. Employment screening, federal regulations, unusual patient behavior, and risk patterns may prompt urine drug screening. Compliance testing may be necessary for patients taking controlled substances. Standard immunoassay testing is fast, inexpensive, and the preferred initial test for urine drug screening. This method reliably detects morphine, codeine, and heroin; however, it often does not detect other opioids such as hydrocodone, oxycodone, methadone, fentanyl, buprenorphine, and tramadol. Unexpected positive test results should be confirmed with gas chromatography/mass spectrometry or high-performance liquid chromatography. A positive test result reflects use of the drug within the previous one to three days, although marijuana can be detected in the system for a longer period of time. Careful attention to urine collection methods can identify some attempts by patients to produce false-negative test results.

摘要

尿液药物筛查可以增强工作场所安全性、监测药物依从性和检测药物滥用。进行这些测试需要了解测试方式、特定药物的检测时间以及假阳性和假阴性结果的常见解释。雇佣筛选、联邦法规、异常患者行为和风险模式可能会促使进行尿液药物筛查。服用受控物质的患者可能需要进行合规性测试。标准免疫测定测试快速、廉价,是尿液药物筛查的首选初始测试。这种方法可靠地检测到吗啡、可待因和海洛因;然而,它通常不能检测到其他阿片类药物,如氢可酮、羟考酮、美沙酮、芬太尼、丁丙诺啡和曲马多。异常的阳性测试结果应使用气相色谱/质谱法或高效液相色谱法进行确认。阳性测试结果反映了在过去一到三天内使用了药物,尽管大麻可能在体内停留更长时间。仔细注意尿液采集方法可以识别一些患者试图产生假阴性测试结果的行为。

相似文献

1
Urine drug screening: a valuable office procedure.尿液药物筛查:一项有价值的门诊程序。
Am Fam Physician. 2010 Mar 1;81(5):635-40.
2
Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).慢性疼痛患者即时检测(POC)或门诊尿液药物检测(免疫测定)准确性的方案:免疫测定和液相色谱串联质谱法(LC/MS/MS)的前瞻性分析。
Pain Physician. 2010 Jan-Feb;13(1):E1-E22.
3
Comparison of three commercial tests for buprenorphine screening in urine.尿液中丁丙诺啡筛查的三种商业检测方法比较
Ann Clin Biochem. 2007 Nov;44(Pt 6):563-5. doi: 10.1258/000456307782268129.
4
Clinical issues associated with urine testing of substances of abuse.与滥用物质尿液检测相关的临床问题。
Pharmacotherapy. 1997 May-Jun;17(3):497-510.
5
An evaluation of the diagnostic accuracy of liquid chromatography-tandem mass spectrometry versus immunoassay drug testing in pain patients.液体色谱-串联质谱法与免疫分析法在疼痛患者药物检测中的诊断准确性评估。
Pain Physician. 2010 May-Jun;13(3):273-81.
6
Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients.比较免疫分析法与液相色谱串联质谱法(LC/MS/MS)尿液药物检测(UDT)在慢性疼痛患者中检测阿片类药物和非法药物的准确性。
Pain Physician. 2011 Mar-Apr;14(2):175-87.
7
Advanced urine toxicology testing.高级尿液毒理学检测。
J Addict Dis. 2010 Oct;29(4):436-48. doi: 10.1080/10550887.2010.509277.
8
The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations.美国联邦工作场所药物检测计划强制指南:现状与未来考量
Forensic Sci Int. 2008 Jan 30;174(2-3):111-9. doi: 10.1016/j.forsciint.2007.03.008. Epub 2007 Apr 16.
9
Drug-testing methods and clinical interpretations of test results.药物检测方法及检测结果的临床解读。
Bull Narc. 1993;45(2):115-54.
10
[On-site testing for drug abuse in urine].[尿液中药物滥用的现场检测]
Tidsskr Nor Laegeforen. 2006 Sep 7;126(17):2257-60.

引用本文的文献

1
A Review of Drug Abuse, Misuse, and Related Laboratory Challenges.药物滥用、误用及相关实验室挑战综述
Curr Drug Saf. 2024;19(4):417-430. doi: 10.2174/0115748863266621231023112044.
2
Comparison of different methods used in drugs of abuse for sample validity testing including pH methods, specific gravity methods, TECO™ Drug Adulteration Test Strip and oxidant assay.用于药物滥用样本有效性检测的不同方法的比较,包括pH值法、比重法、TECO™药物掺假检测试纸条和氧化剂检测法。
Adv Lab Med. 2021 Jun 4;2(4):550-566. doi: 10.1515/almed-2021-0026. eCollection 2021 Nov.
3
Review of the Current State of Urine Drug Testing in Chronic Pain: Still Effective as a Clinical Tool and Curbing Abuse, or an Arcane Test?
慢性疼痛中尿液药物检测的现状评估:作为临床工具仍然有效并能遏制滥用,还是一种神秘的检测方法?
Curr Pain Headache Rep. 2021 Feb 17;25(2):12. doi: 10.1007/s11916-020-00918-z.
4
Program Evaluation of Group Transcending Self Therapy: An Integrative Modular Cognitive-Behavioral Therapy for Substance Use Disorders.团体超越自我疗法的项目评估:一种针对物质使用障碍的综合模块化认知行为疗法
Subst Abuse. 2020 Aug 17;14:1178221820947653. doi: 10.1177/1178221820947653. eCollection 2020.
5
Effect of urine adulterants on commercial drug abuse screening test strip results.尿液掺杂剂对商业药物滥用筛查检测试纸结果的影响。
Arh Hig Rada Toksikol. 2020 Mar 1;71(1):87-93. doi: 10.2478/aiht-2020-71-3315.
6
Urine drug screens: Considerations for the psychiatric pharmacist.尿液药物筛查:精神科药剂师的考量因素
Ment Health Clin. 2016 Mar 8;6(1):42-47. doi: 10.9740/mhc.2016.01.042. eCollection 2016 Jan.
7
Importance of Urinary Drug Screening in the Multiple Sleep Latency Test and Maintenance of Wakefulness Test.尿液药物筛查在多次睡眠潜伏期试验和清醒维持试验中的重要性。
J Clin Sleep Med. 2016 Dec 15;12(12):1633-1640. doi: 10.5664/jcsm.6348.
8
Amphetamine Abuse Related Acute Myocardial Infarction.苯丙胺滥用相关的急性心肌梗死
Case Rep Cardiol. 2016;2016:7967851. doi: 10.1155/2016/7967851. Epub 2016 Feb 21.
9
Tramadol overdose and apnea in hospitalized children, a review of 20 cases.住院儿童曲马多过量与呼吸暂停:20例病例回顾
Res Pharm Sci. 2015 Nov-Dec;10(6):544-52.
10
Current and Future Prospects for Epigenetic Biomarkers of Substance Use Disorders.物质使用障碍的表观遗传生物标志物的现状和未来前景。
Genes (Basel). 2015 Oct 14;6(4):991-1022. doi: 10.3390/genes6040991.